Methotrexate for refractory Crohn's disease: preliminary answers to definitive questions
- PMID: 8538222
- DOI: 10.4065/71.1.104
Methotrexate for refractory Crohn's disease: preliminary answers to definitive questions
Comment on
-
Methotrexate for inflammatory bowel disease: pharmacology and preliminary results.Mayo Clin Proc. 1996 Jan;71(1):69-80. doi: 10.4065/71.1.69. Mayo Clin Proc. 1996. PMID: 8538238 Review.
Similar articles
-
Methotrexate treatment for Crohn's disease.Inflamm Bowel Dis. 1998 May;4(2):120-1. doi: 10.1097/00054725-199805000-00018. Inflamm Bowel Dis. 1998. PMID: 9687221 No abstract available.
-
Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment.Postgrad Med J. 2010 Apr;86(1014):208-11. doi: 10.1136/pgmj.2009.085787. Postgrad Med J. 2010. PMID: 20354043
-
Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.Inflamm Bowel Dis. 2012 Aug;18(8):1488-92. doi: 10.1002/ibd.21885. Epub 2011 Aug 31. Inflamm Bowel Dis. 2012. PMID: 21882301
-
Use of methotrexate in patients with inflammatory bowel diseases.Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S151-5. Epub 2010 Oct 28. Clin Exp Rheumatol. 2010. PMID: 21044450 Review.
-
Safety profile of methotrexate in inflammatory bowel disease.Expert Opin Drug Saf. 2016 Oct;15(10):1427-37. doi: 10.1080/14740338.2016.1218468. Epub 2016 Aug 8. Expert Opin Drug Saf. 2016. PMID: 27462711 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical